Elżbieta Petriczko

Elżbieta Petriczko serves as Professor at the Department of Pediatrics, Endocrinology, Diabetology, Metabolic Disease and Cardiology of the Development Age within the Faculty of Medicine at Pomeranian Medical University in Szczecin, Poland. Her research career—spanning over two decades since her 2001 doctorate and culminating in her 2025 promotion to full Professor—focuses on critical issues in pediatric metabolic health with 201 publications and 7 promoted theses to her credit.

Her primary research interests center on childhood obesity (particularly severe and early-onset forms), type 1 and type 2 diabetes, growth hormone disorders, and metabolic complications in children. Through Polish-German multicenter collaborations, she investigates real-world clinical challenges including leptin dysfunction, metabolic-associated fatty liver disease (MAFLD), cardiovascular risks in obesity, and treatment compliance in growth hormone therapy. Her work frequently addresses healthcare access gaps, as evidenced by her 2025 study revealing a 7-year delay in specialized obesity care in Poland.

Analysis of her 15 most recent publications (2023-2025) shows a dominant focus on severe childhood obesity complications and novel growth disorder treatments. Key trends include metabolic phenotyping of obese children, cardiovascular risk stratification beyond BMI, and evaluation of emerging therapies like oral LUM-201 for growth hormone deficiency. Her Polish-German collaborative projects consistently generate clinically actionable insights for pediatric endocrine practice.

Professor Petriczko has secured funding for 2 research projects and received 4 institutional achievements, though specific award names remain unlisted in available records. Her mentorship of 7 graduate students underscores her academic leadership, while her clinical work directly impacts management protocols for conditions ranging from extreme obesity complications to rare genetic growth disorders.